Published in Cancer on June 01, 1977
Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J (Clin Res Ed) (1987) 1.36
Adjuvant chemotherapy for breast cancer: side effects and quality of life. Br Med J (1980) 1.31
Multimodal treatment in operable breast cancer: five-year results of the CMF programme. Br Med J (Clin Res Ed) (1981) 1.21
Meta-analysis as a manifestation of 'bondförnuft' ('peasant sense'). J R Soc Med (2010) 1.07
Correlation of estrophilin content of primary mammary cancer to eventual endocrine treatment. Ann Surg (1978) 1.06
Adjuvant chemotherapy and immunotherapy for colorectal cancer: preliminary communication. J R Soc Med (1980) 0.97
Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Breast Cancer Res Treat (2012) 0.92
Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study. Br J Cancer (1995) 0.90
Content of low density lipoprotein receptors in breast cancer tissue related to survival of patients. Br Med J (Clin Res Ed) (1986) 0.81
Controversies in the medical management of breast cancer. Postgrad Med J (1985) 0.79
Decreased production of soluble interleukin 2 receptor by phytohaemagglutinin-stimulated peripheral blood mononuclear cells in patients with breast cancer after adjuvant therapy. Br J Cancer (1989) 0.79
The prognosis of breast cancer patients in relation to the oestrogen receptor status of both primary disease and involved nodes. Br J Cancer (1992) 0.79
Toxicity of oral adjuvant chemotherapy in breast cancer. Br Med J (1978) 0.79
Preliminary results of primary systemic chemotherapy in association with surgery or radiotherapy in rapidly progressing breast cancer. Br J Cancer (1982) 0.78
The effect of combination chemotherapy on ovarian, hypothalamic and pituitary function in patients with breast cancer. Arch Gynecol (1979) 0.77
Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer. BMC Surg (2015) 0.75
Update on cancer chemotherapy: general considerations and breast cancer. Part II. J Natl Med Assoc (1985) 0.75
Management of breast cancer: what do I tell the patient? Can Fam Physician (1986) 0.75
Breast cancer: a case for conservation. Br Med J (Clin Res Ed) (1981) 0.75
Cancer chemotherapy. J R Soc Med (1979) 0.75
Primary treatment of breast cancer by modified radical mastectomy, radiotherapy, and chemotherapy. Ann R Coll Surg Engl (1980) 0.75
Clinical and radiological evaluation of patients with lytic, mixed and sclerotic bone metastases from solid tumors: is there a correlation between clinical status of patients and type of bone metastases? Clin Exp Metastasis (2007) 0.75
Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med (1976) 9.68
Comparison of the genomes of two Xanthomonas pathogens with differing host specificities. Nature (2002) 8.42
Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med (1981) 7.53
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med (1995) 6.44
Breast cancer (1) N Engl J Med (1992) 4.79
Overview of the main outcomes in breast-cancer prevention trials. Lancet (2003) 4.31
Results of a breast-cancer-surgery trial compared with observational data from routine practice. Lancet (1996) 3.78
Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med (1977) 3.45
Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. Eur J Cancer (1990) 3.01
The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J (2002) 2.84
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med (1997) 2.73
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer (1982) 2.71
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. J Clin Oncol (1998) 2.59
Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer (1975) 2.52
Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med (1981) 2.50
Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans. J Clin Oncol (1995) 2.50
Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results. JAMA (1995) 2.44
Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer (1981) 2.40
A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation. Eur Respir J (2005) 2.39
Local recurrences following mastectomy: support for the concept of tumor dormancy. J Natl Cancer Inst (1994) 2.34
Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol (2004) 2.31
Estimation of oxygen delivery in newborns with a univentricular circulation. Circulation (1998) 2.26
Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst (1990) 2.25
Refined crystal structure of ascorbate oxidase at 1.9 A resolution. J Mol Biol (1992) 2.18
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Sirenomelia. Pathological features, antenatal ultrasonographic clues, and a review of current embryogenic theories. Hum Reprod Update (1999) 2.12
The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst (1994) 2.06
Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. Eur J Cancer Clin Oncol (1986) 2.05
Alteration of the platelet serotonin transporter in romantic love. Psychol Med (1999) 2.02
X-ray crystal structure of the blue oxidase ascorbate oxidase from zucchini. Analysis of the polypeptide fold and a model of the copper sites and ligands. J Mol Biol (1989) 1.90
Clinical evaluation of adriamycin, a new antitumour antibiotic. Br Med J (1969) 1.89
P0.1 is a useful parameter in setting the level of pressure support ventilation. Intensive Care Med (1995) 1.88
Three-year assessment of methicillin-resistant Staphylococcus aureus clones in Latin America from 1996 to 1998. J Clin Microbiol (2001) 1.88
Segmental spinal dysgenesis: neuroradiologic findings with clinical and embryologic correlation. AJNR Am J Neuroradiol (1999) 1.86
Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer (1978) 1.75
Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study. Cancer (1976) 1.75
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. Ann Oncol (2006) 1.74
Drugs ten years later: epirubicin. Ann Oncol (1993) 1.74
The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer (1999) 1.73
Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst (2001) 1.68
Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancer. Eur J Cancer (1998) 1.68
Labeling index as a prognostic marker in non-Hodgkin's lymphomas. J Natl Cancer Inst (1981) 1.68
SVCT1 and SVCT2: key proteins for vitamin C uptake. Amino Acids (2007) 1.67
Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer. Cancer (1983) 1.65
Patterns of second malignant neoplasms in children. Cancer (1977) 1.65
Physiologic effects of positive end-expiratory pressure and mask pressure support during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1994) 1.63
Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy. Breast Cancer Res Treat (1996) 1.61
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD. J Clin Oncol (1997) 1.61
Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy. Am J Cardiol (1998) 1.60
Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer. J Natl Cancer Inst (1997) 1.60
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol (1987) 1.57
Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet (1989) 1.57
Striking differences between the kinetics of regulation of respiration by ADP in slow-twitch and fast-twitch muscles in vivo. Eur J Biochem (1996) 1.56
Molecular epidemiologic characterization of penicillin-resistant Streptococcus pneumoniae invasive pediatric isolates recovered in six Latin-American countries: an overview. PAHO/Rockefeller University Workshop. Pan American Health Organization. Microb Drug Resist (1998) 1.54
Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer. Ann Oncol (1994) 1.54
Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med (1998) 1.53
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J Clin Oncol (1990) 1.53
Mutation in a calpain-like protease affects the posttranslational mannosylation of phosphatases in Aspergillus nidulans. Fungal Genet Biol (2003) 1.52
Laparoscopy and laparotomy combined with bone marrow biopsy in staging Hodgkin's disease. Br Med J (1975) 1.52
Initial chemotherapy for primary resectable large-cell lymphoma of the stomach. Ann Oncol (1997) 1.51
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat (1985) 1.51
Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia (2006) 1.51
Phase I and preliminary phase II evaluation of adriamycin (NSC 123127). Cancer Res (1970) 1.50
Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg (1983) 1.50
Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity. Eur J Neurol (2011) 1.50
The Bonfils fiberscope: a clinical evaluation of its learning curve and efficacy in difficult airway management. Minerva Anestesiol (2011) 1.50
Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancer. Ann Oncol (1994) 1.50
Spinal dysraphism: a review of neuroradiological features with embryological correlations and proposal for a new classification. Neuroradiology (2000) 1.49
The trials of Dr. Bernard Fisher: a European perspective on an American episode. Control Clin Trials (1997) 1.49
Are surgical adjuvant trials altering the course of breast cancer? Semin Oncol (1978) 1.49
Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trials. J Natl Cancer Inst (1990) 1.49
Adjuvant chemotherapy of breast cancer. Br J Hosp Med (1980) 1.48
LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood (1994) 1.48
Florence statement on breast cancer, 1998 forging the way ahead for more research on and better care in breast cancer. Eur J Cancer (1999) 1.48
Distribution of axillary node metastases by level of invasion. An analysis of 539 cases. Cancer (1987) 1.48